Should DHA be Continued at 34 Weeks Gestation?
Yes, continue daily DHA supplementation through 37 weeks of gestation or until delivery, whichever comes first.
Rationale Based on Guidelines
The most recent international guidelines consistently recommend that DHA supplementation should continue until approximately 37 weeks of gestation 1. At 34 weeks, you are still within the critical window where DHA supplementation provides benefit for reducing preterm birth risk.
Specific Timing Recommendations
Multiple guidelines establish clear timing parameters:
- Start: Ideally before 20 weeks gestation (second trimester)
- Continue: Until 37 weeks of gestation or delivery if before 37 weeks 2
- Do not stop early: The protective effect against preterm birth requires continuation through late pregnancy 3
The evidence shows that stopping DHA at 34 weeks would be premature, as the supplementation period should extend to term (37 weeks) to maximize the reduction in preterm birth risk 4, 2.
Dosing at This Stage
At 34 weeks, the recommended daily intake remains:
- Standard pregnancy: 200 mg/day DHA minimum, with total omega-3 (EPA+DHA) of 300-500 mg/day 1
- Women at higher risk of preterm birth (low baseline DHA intake or omega-3 index <4%): 600-1000 mg/day DHA+EPA 3, 2, 5
The Australian clinical practice guideline specifically recommends at least 500 mg DHA daily from 12 weeks gestation to reduce preterm birth risk 1.
Key Evidence Supporting Continuation
A 2025 randomized controlled trial found that starting DHA supplementation only after threatened preterm labor was diagnosed (between 24-34 weeks) did not reduce preterm birth rates 4. This underscores that DHA must be taken consistently from early/mid-pregnancy through 37 weeks for maximum benefit—not started late or stopped early.
The 2024 clinical practice guideline emphasizes that women with low DHA status have increased risk of preterm birth <34 weeks, and supplementation should continue until approximately 37 weeks 2.
Safety Considerations
The FDA drug label notes that doses >3 grams/day may have anti-thrombotic effects 6. However, the recommended pregnancy doses (200-1000 mg/day) are well below this threshold and considered safe. The label indicates DHA is appropriate "throughout pregnancy and during the postnatal period" 6.
Common Pitfall to Avoid
Do not discontinue DHA prematurely at 34 weeks. The protective window for preterm birth prevention extends through 37 weeks. Early discontinuation negates the cumulative benefit of supplementation throughout pregnancy. The research clearly shows that DHA supplementation initiated late in pregnancy (after threatened preterm labor) is ineffective 4, suggesting the importance of sustained supplementation through the recommended gestational age.
Transition to Postpartum
After delivery or at 37 weeks, transition to lactation dosing recommendations of 200 mg/day DHA to support infant neurodevelopment through breast milk 1.